Syngene expands research collaboration with Bristol Myers Squibb

Syngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more services for drug development, from discovery to manufacturing. The collaboration, which began in 1998, will now focus on building new capabilities for future programs. This move aims to accelerate the delivery of new medicines to patients worldwide.